TuHURA Biosciences, Inc./NV (HURA)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
In fiscal 2025, TuHURA Biosciences, Inc./NV reported revenue of $0. The company ran a net loss. It held $27.35M in total assets against $6.42M in total liabilities.
Key ratios (FY2025)
-143.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | — | — | — | — | — | — | — |
| Net Income | -$30.05M | -$21.68M | -$29.32M | -$22.66M | -$38.30M | -$9.13M | -$8.05M | $11.14M | $8.08M | $8.86M |
| EPS (Diluted) | $-0.63 | $-1.21 | $-2.47 | $-25.80 | $-1.60 | $-0.87 | $3.16 | $5.42 | $0.74 | $0.83 |
| Total Assets | $27.35M | $19.97M | $4.36M | $15.95M | $13.54M | $2.94M | $4.04M | $7.07M | $7.91M | $6.36M |
| Total Liabilities | $6.42M | $5.37M | $5.92M | $4.15M | $2.96M | $2.67M | $2.07M | $1.64M | $1.33M | $1.50M |
| Shareholders' Equity | $20.93M | $14.59M | -$1.56M | $12.30M | $10.58M | $263.0K | $1.97M | $5.44M | $6.58M | $4.86M |
| Cash & Equivalents | $3.62M | $12.66M | $3.67M | $11.78M | $10.54M | $2.39M | $3.72M | $5.97M | $6.59M | $6.16M |
| Operating Cash Flow | -$27.63M | -$14.73M | -$11.95M | -$20.39M | -$18.86M | -$7.93M | -$6.33M | -$9.85M | -$8.02M | -$5.15M |
| Capital Expenditures | $76.1K | $57.9K | $79.2K | — | — | — | — | — | — | — |
| Shares Outstanding | 59.34M | 12.17M | 12.17M | — | — | — | 7.8K | 91.3K | 982.8K | 1.01M |